Development of the RTS,S/AS malaria candidate vaccine
- 30 December 2009
- Vol. 27, G67-G71
- https://doi.org/10.1016/j.vaccine.2009.10.013
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican ChildrenPLOS ONE, 2009
- A World Malaria Map: Plasmodium falciparum Endemicity in 2007PLoS Medicine, 2009
- Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in InfantsNew England Journal of Medicine, 2008
- Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of AgeNew England Journal of Medicine, 2008
- Malaria: progress, perils, and prospects for eradicationJournal of Clinical Investigation, 2008
- Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of ResearchVaccine, 2008
- Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02AVaccine, 2006
- Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian childrenVaccine, 2005
- Attributable fraction estimates and case definitions for malaria in endemicStatistics in Medicine, 1994
- Immunity to Malaria and Naturally Acquired Antibodies to the Circumsporozoite Protein ofPlasmodium falciparumNew England Journal of Medicine, 1986